WO2023242736 - MODULAR MANUFACTURING FOR PHARMACEUTICALS
National phase entry:
Publication Number
WO/2023/242736
Publication Date
21.12.2023
International Application No.
PCT/IB2023/056095
International Filing Date
13.06.2023
Title **
[English]
MODULAR MANUFACTURING FOR PHARMACEUTICALS
[French]
FABRICATION MODULAIRE DE PRODUITS PHARMACEUTIQUES
Applicants **
BEREN THERAPEUTICS P.B.C.
Inventors
PFEIFFER, Steven
RIZKIN, Benjamin
Priority Data
63/351,716
13.06.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2808 | |
| EPO | Filing, Examination, Granting | 12832 | |
| Japan | Filing, Examination, Granting | 2306 | |
| South Korea | Filing, Examination, Granting | 2288 | |
| USA | Filing, Examination, Granting | 5790 |
Total:
26,024
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
Provided herein is a modular system for the production of pharmaceuticals. The system's modular design allows for customization and efficient operation of the system, as well as the ability to deliver pharmaceuticals on demand.[French]
L'invention concerne un système modulaire pour la production de produits pharmaceutiques. La conception modulaire du système permet une personnalisation et un fonctionnement efficace du système, ainsi que la capacité de distribuer des produits pharmaceutiques à la demande.